Increasing rates of melanoma seen in the U.S.

melanoma skin cancerMelanoma – skin cancer – rates are climbing in the U.S., according to latest research findings. This year’s estimates for melanoma cases are at one in every 54 Americans. In 2009, it was estimated at one in every 58. Overall, it was estimated that 76,380 people will be diagnosed with melanoma in 2016.

Dr. Alex Glazer, research lead exploring melanoma rates, said, “The overall burden of disease for melanoma is increasing.”


Skin cancer is growing to be one of the most common forms of cancer among Americans. Although in the majority of cases, melanomas can be removed and treated, some can be life-threatening.
The researchers found an increase in “in situ” (without spread) melanoma from one in every 78 persons back in 2009 to one in every 58 persons in 2016. The researchers suspect that this increase in rates is a result of better detection methods.

When in situ cases and tumor cases of melanoma were combined, the researchers suspect that one in every 28 Americans will encounter some form of melanoma within their lifetime.

If caught in its early stage, melanoma can be treated, but more invasive tumors can have deadly outcomes.

It’s important that Americans practice sun safety and speak to their doctors if they notice a new or large mole right away.

Author Bio

Mohan Garikiparithi got his degree in medicine from Osmania University (University of Health Sciences). He practiced clinical medicine for over a decade before he shifted his focus to the field of health communications. During his active practice he served as the head of the Dept. of Microbiology in a diagnostic centre in India. On a three-year communications program in Germany, Mohan developed a keen interest in German Medicine (Homoeopathy), and other alternative systems of medicine. He now advocates treating different medical conditions without the use of traditional drugs. An ardent squash player, Mohan believes in the importance of fitness and wellness.


Related Reading:

Celiac disease is not a colon cancer or melanoma risk factor

Vitiligo may predict immunotherapy response in melanoma patients

Popular Stories